Portfolio company
RESPINOR
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops non-invasive ultrasound devices for continuous diaphragm monitoring in critically ill patients undergoing mechanical ventilation within intensive care settings.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Deep Breath
This company develops AI-driven decision support systems to optimise mechanical lung ventilation settings for clinicians working in intensive care units.
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
Esperto Medical
This medical technology company develops non-invasive, continuous blood pressure monitoring devices using ultrasound for healthcare providers and patients.
Flosonics Medical
This company develops wearable Doppler ultrasound sensors that monitor blood flow for clinicians treating patients in emergency and intensive care settings.
GlucoSet
The company develops an intravascular sensor that provides continuous blood glucose monitoring for critically ill patients in intensive care units.
Cimon Medical
This company develops Doppler ultrasound technology for continuous blood flow monitoring in premature and critically ill infants within healthcare facilities.
Volusense
The company develops non-invasive, mask-free respiratory monitoring systems used by neonatologists and paediatricians to evaluate lung function in preterm and term infants.
